Lexeo Therapeutics stockholders elect Class I director, ratify KPMG as auditor

Lexeo Therapeutics, Inc.

Mette Kirstine Agger elected Class I director with 14,499,254 FOR, 7,450,057 WITHHELD, 1,249,160 broker non-votes.
Ratification of KPMG LLP as auditor for FY2024 passed: 23,194,982 FOR, 3,088 AGAINST, 401 ABSTAIN.
Annual meeting held virtually on June 25, 2024; no other proposals were voted on.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.